Supplementary Fig. 2 from Targeting the ERα DBD–LBD Interface with Mitoxantrone Disrupts Receptor Function through Proteasomal Degradation
Abstract
Supplementary Fig. 2: MTO demonstrates enhanced growth inhibition in endocrine-resistant T47D cells
Fields of Study & Subjects
Melanoma and MAPK Pathways
Cellular transport and secretion
Protein Degradation and Inhibitors
Publication details
- Publisher
- American Association for Cancer Research (AACR)
- Publication date
- 2 January 2026